Enterocyte

Enterocytes are the predominant cell type of the intestinal epithelium, primarily responsible for the absorption of nutrients, electrolytes, and water from the intestinal lumen [1]. These polarized columnar cells feature a specialized apical surface known as the brush border, which is composed of microvilli that significantly increase the surface area available for digestion and transport via membrane-bound enzymes and transporters [2]. Beyond their absorptive role, enterocytes function as a critical physical and immunological barrier, preventing the translocation of luminal pathogens while participating in mucosal immune sensing [1, 2]. Dysfunction or destruction of enterocytes is a hallmark of various gastrointestinal disorders, such as Celiac disease, where immune-mediated damage leads to villous atrophy and profound malabsorption [2]. While the term "enterocyte" refers to a cell type rather than a single molecular target, these cells express numerous specific proteins—including NPC1L1, SGLT1, and Guanylate cyclase-C—that serve as therapeutic targets for treating hypercholesterolemia, diabetes, and chronic constipation [4, 5]. Sources: [1] StatPearls, Physiology, Small Bowel; [2] NIH, The Enterocyte; [3] PubMed, Short Bowel Syndrome Management; [4] PubChem, Ezetimibe; [5] FDA, Linzess (linaclotide) Label; [6] FDA, Gattex (teduglutide) Label; [7] PubMed, Tenapanor Mechanism; [8] PubMed, Biomarkers of Intestinal Damage; [9] PubMed, Citrulline as a marker of enterocyte mass; [10] PubMed, Zonulin and intestinal permeability.

Other names

Intestinal epithelial cellAbsorptive cellIntestinal columnar cellIntestinal absorptive cell

Pharmacological agents do not target the enterocyte as a whole but rather interact with specific proteins expressed on its surface or within its cytoplasm, such as ion transporters (NHE3), receptors (GC-C), or cholesterol transporters (NPC1L1), to modulate intestinal absorption, secretion, or epithelial growth [4, 5, 7].